Must admit, I had to re-read the announcement today to remain confident. I think the most import takeaways for me are the timeline.
2nd Dec 2015 - Unilife and Amgen enter into a Master Feasibility and Customization Agreement
31st Dec 2015 - Unilife and Amgen enter into a Material Definitive Agreement
Amgen have clearly done their homework and decided Unilife have technology they want/need. We'll find out in the next few days
1 - How they want to structure their deal(s) with Unilife and
2 - What they are willing to pay for it
I don't think exclusive licensing for the 1ml technologies and future enhancement will be cheap.
UNS Price at posting:
22.5¢ Sentiment: Hold Disclosure: Held